glp 1 drug novo nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article Novo Nordisk justifies reasoning behind
Description
Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to suggest drugs like Ozempic contribute to vision loss.
Farxiga can cost up to $600 without insurance, depending on the pharmacy and brand choice
2017;21(5):1160-8
The United States is still deciding how exactly to approach GLP-1s
